# Iowa Capital Management

> Iowa Capital Management is a VC fund in Fairfield backing Genetics and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Fairfield, United States
- Total investments: 2
- Last investment: Jan 2008
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.iowacapital.com

Iowa Capital Management is a VC fund in Fairfield focused on Genetics and Health Care. owa Capital Management, Inc., is a federally licensed Commodities firm, specializing in Professionally Managed Futures Investments. They find money managers with exceptional performance records in commodity futures trading.Iowa Capital Management, Inc. is a registered Introducing Brokerage with the Commodity Futures Trading Commission, is amember of the National Futures Association and the National Introducing Brokers Association.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NewLink Genetics | NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. | $17M | Series C | Jan 31, 2008 |  |
| NewLink Genetics | NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. | $8.2M | Series B | Sep 07, 2007 |  |

2 of 2 investments shown.

## Co-investors
- [Ames Seed Capital](https://shizune.co/investors/profile/ames-seed-capital) — VC Fund, 2 deals together
- Midwest Oilseeds — VC Fund, 2 deals together
- NLG Advisors — VC Fund, 2 deals together
- Chicagoland Investors — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Iowa Capital Management invest in?

Iowa Capital Management invests primarily in Genetics, Health Care and Therapeutics startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Iowa Capital Management last invest?

The most recent investment recorded for Iowa Capital Management closed in Jan 2008. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co